RETA insider trading

REATA PHARMACEUTICALS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
674
Last 90 days
0
Buys / sells
29% / 33%
Market cap

RETA insider activity at a glance

FilingIQ has scored 674 insider transactions for RETA since May 25, 2016. The most recent filing in our index is dated Sep 26, 2023.

Across the full history, 194 open-market purchases and 223 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on RETA insider trades is 57.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest RETA Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for RETA?
FilingIQ tracks 674 Form 4 insider transactions for RETA (REATA PHARMACEUTICALS INC), covering filings from May 25, 2016 onwards. 0 of those were filed in the last 90 days.
Are RETA insiders net buyers or net sellers?
Across the full Form 4 history for RETA, 194 transactions (29%) were open-market purchases and 223 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RETA insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every RETA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.